M12 logo

M1 Kliniken AG Stock Price

XTRA:M12 Community·€340.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 26 Fair Values set on narratives written by author

M12 Share Price Performance

€18.34
2.82 (18.17%)
€18.34
2.82 (18.17%)
Price €18.34

M12 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

1 Risk
2 Rewards

M1 Kliniken AG Key Details

€364.3m

Revenue

€311.4m

Cost of Revenue

€52.9m

Gross Profit

€30.8m

Other Expenses

€22.1m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.19
14.53%
6.08%
2.1%
View Full Analysis

About M12

Founded
2007
Employees
280
CEO
Attila Strauss
WebsiteView website
www.m1-kliniken.de

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.

Recent M12 News & Updates

Analysis Article May 27

M1 Kliniken's (ETR:M12) Strong Earnings Are Of Good Quality

The subdued stock price reaction suggests that M1 Kliniken AG's ( ETR:M12 ) strong earnings didn't offer any surprises...

Recent updates

No updates